Diphtheria medical therapy

Jump to navigation Jump to search

Diphtheria Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Causes

Differentiating Diphtheria from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

X Ray

CT

MRI

Electrocardiogram

Echocardiography

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Diphtheria medical therapy On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Diphtheria medical therapy

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Diphtheria medical therapy

CDC on Diphtheria medical therapy

Diphtheria medical therapy in the news

Blogs on Diphtheria medical therapy

Directions to Hospitals Treating Diphtheria

Risk calculators and risk factors for Diphtheria medical therapy

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Kalsang Dolma, M.B.B.S.[2], Dima Nimri, M.D. [3]

Overview

Treatment of diphtheria consists of the administration of the diphtheria antitoxin (if the disease is identified early), administration of the right antibiotic therapy, as well as the identification of individuals in close contact with the patient, so that they may be provided with the appropriate prophylaxis.[1][2][3][4][5][6]

Medical Therapy

Treatment of diphtheria consists of the administration of the diphtheria antitoxin (if the disease is identified early), administration of the right antibiotic therapy, as well as the identification of individuals in close contact with the patient, so that they may be provided with the appropriate prophylaxis.[1][2][3][4][5][6]

  • 1. Antitoxin
  • 1.1 Pharyngeal disease <48 hrs
  • Preferred regimen: 20,000-40,000 U IV/IM
  • 1.2 Nasopharyngeal
  • Preferred regimen: 40-60,000 U IV/IM
  • 1.3 Extensive disease, or > 72 hrs
  • Preferred regimen: 80-120,000 U IV/IM
  • Note: IV administration may be suitable for severe disease
  • 2. Antibiotics
  • Preferred regimen: Erythromycin 40 mg/kg/day (Maximum, 2 gm/day) PO/IV for 14 days
  • Alternative regimen: Procaine penicillin G 600,000 U/day IM qd for 14 days
  • Note: Procaine penicillin G 300,000 U/day for those who weigh 10 kg or less
  • 3. Preventive antibiotic use
  • Note: For close contacts, especially household contacts, an age-appropriate diphtheria booster should be given
  • Preferred regimen: Benzathine penicillin G
  • younger than 6 years old: 600,000 U IM
  • 6 years old and older: 1,200,000 U IM
  • Adult: 1 g/day PO 7-10 days
  • Pediatric: 40 mg/kg/day PO 7-10 days
  • Note (1): If surveillance of contacts cannot be maintained, they should be given benzathine penicillin G
  • Note (2): Maintain close surveillance and begin antitoxin at the earliest signs of illness

References

  1. 1.0 1.1 Bartlett, John (2012). Johns Hopkins ABX guide : diagnosis and treatment of infectious diseases. Burlington, MA: Jones and Bartlett Learning. ISBN 978-1449625580.
  2. 2.0 2.1 "Diphtheria CDC".
  3. 3.0 3.1 Park WH, Atkinson JP (1898). "THE RELATION OF THE TOXICITY OF DIPHTHERIA TOXIN TO ITS NEUTRALIZING VALUE UPON ANTITOXIN AT DIFFERENT STAGES IN THE GROWTH OF CULTURE". J. Exp. Med. 3 (4–5): 513–32. PMC 2117979. PMID 19866893.
  4. 4.0 4.1 Kneen R, Pham NG, Solomon T, Tran TM, Nguyen TT, Tran BL, Wain J, Day NP, Tran TH, Parry CM, White NJ (1998). "Penicillin vs. erythromycin in the treatment of diphtheria". Clin. Infect. Dis. 27 (4): 845–50. PMID 9798043.
  5. 5.0 5.1 Miller LW, Bickham S, Jones WL, Heather CD, Morris RH (1974). "Diphtheria carriers and the effect of erythromycin therapy". Antimicrob. Agents Chemother. 6 (2): 166–9. PMC 444622. PMID 15828187.
  6. 6.0 6.1 Farizo KM, Strebel PM, Chen RT, Kimbler A, Cleary TJ, Cochi SL (1993). "Fatal respiratory disease due to Corynebacterium diphtheriae: case report and review of guidelines for management, investigation, and control". Clin. Infect. Dis. 16 (1): 59–68. PMID 8448320.




Template:WikiDoc Sources